Fouad Azzam
InvestorPartner at EQT Life Sciences
Boston, Massachusetts
Writes $11M β $65M checks Β· typically $25M
About
Fouad Azzam is a Partner at EQT Life Sciences focused on multi-stage venture capital investment in biotechnology and medical technology companies. He brings operating experience and board-level expertise across public and private companies, with service on audit, compensation, and transaction committees. His background spans corporate strategy, capital allocation, mergers and acquisitions, and governance in healthcare, medical devices, biotechnology, and pharmaceuticals.
Experience
- EQT Life SciencesPartnercurrent2007 β presentBoston, Massachusetts, United States
- Neuros Medical, Inc.Board Membercurrent2025 β present
- Shinobi TherapeuticsBoard Membercurrent2023 β present
- HotSpot Therapeutics, Inc.Board Membercurrent2021 β presentBoston, Massachusetts, United States
- XyloCor TherapeuticsBoard Membercurrent2018 β present
- Cardiac DimensionsBoard Member2015 β 2025
- Endotronix, Inc.Board Member2018 β 2024lisle, IL
- Nkarta Therapeutics, IncBoard Member2019 β 2024
- DOTS Technology CorpBoard Member2021 β 2023Natick, Massachusetts, United States
- LSP (Life Sciences Partners)General Partner2007 β 2022Greater Boston
- Simplify Medical, Inc.Board Member2017 β 2021Sunnyvale, CA
- Rainier TherapeuticsBoard Member2016 β 2020San Ramon, CA
- IlluminOss MedicalChairman Of The Board2012 β 2020East Providence, RI
- Rotation MedicalBoard Member2014 β 2017Plymouth, MN
- Harvest Automation Inc.Board Member2009 β 2016
- Seahorse BioscienceBoard Member2007 β 2015North Billerica, MA
- Cobalt TechnologiesBoard Member2008 β 2015
- Celladon CorporationBoard Member2012 β 2014San Diego, CA
- Pasteuria BioscienceBoard Member2007 β 2012Gainesville, FL
- FlowCardiaBoard Member2007 β 2010Sunnyvale, CA
Education
- University at Buffalo School of Management, The State University of New YorkM.B.A.1997 β 1999
- The University of AkronPh.D., Chemical Engineering1991 β 1993
- The University of AkronB.S. & M.S., Chemical Engineering1984 β 1991
Skills & more
Venture Capital49Strategic Planning21Lifesciences20Biotechnology17Medical Devices18Mergers7Start-ups20Mergers & Acquisitions42Pharmaceutical Industry9Technology Transfer5Business Development21Patents3
+11 more
StrategyCommercializationCorporate DevelopmentR&DManagementCross-functional Team LeadershipProduct DevelopmentEntrepreneurshipDue DiligenceVenture FinancingLife SciencesFrom Fouad's professional profile.
Same school
Also attended University at Buffalo School of Management, The State University of New York12
David FallaceManaging Partner at Cure VenturesJoshua GilbertInvestor at TMV LogisticsDaniel PenberthyPresident and Chief Executive Officer at Rand CapitalKunal SinhaVenture Partner at Zero Infinity PartnersBill DrmacichManaging Director at SG Credit PartnersRaymond DenneyPartner/COO/CCO at Wakem Capital Management
+ 6 more
Also attended The University of Akron11
Liam McAllisterAnalyst at Miami University Redhawk VenturesKat CreamerOperations Manager at Red Cell IncubationFreddie CoffeySenior Director, Marketing at JumpStart VenturesJΓ©ssica BortolatoOperating Partner at Parceiro VenturesAmani AlshaikhmubarakDirector, Saudi Arabia at Orbit StartupsAaron BrownSecurity Advisor at Modern Technical
+ 5 more
Shared employers
Also worked at Shinobi Therapeutics1
Also worked at Cardiac Dimensions2
Also worked at Nkarta Therapeutics, Inc1
Also worked at FlowCardia2
Colleagues at EQT Life Sciences
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christina Drews
Chief Operating Officer at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences
Network5
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences
Investors connected to Fouad in public investor directories β a warm-intro map.


























